Validation Study of an Assistive Pulse Data Collection Device

Recruiting Phase 1 Interventional Study
Healthy Male and Female Subjects
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Other
Participants needed
30 (estimated)
Sponsor
The Hong Kong Polytechnic University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Background: Traditional Chinese Medicine (TCM) relies on pulse diagnosis, a subjective and complex method that is crucial for assessing patients' health status. The COVID-19 pandemic has disrupted healthcare delivery, highlighting the need for remote diagnostic tools. To address this, an Assistive Pulse Data Collection Device (APDC) has been developed to capture and regenerate pulse features for r…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age 18-65 years 2. BMI 18.5-22.5 kg/m2 3. Willing to give informed consent Exclusion Criteria: 1\. dorsally located radial artery
Contacts

WF Yeung, Ph.D

852-27664151

jerry-wf.yeung@polyu.edu.hik

CONTACT